AWS series is an initiative by DRILS for fostering the culture of deliberating and acquainting research team on the science that is done at CIMPS, Center for Innovation in Molecular and Pharmaceutical Sciences. It is intended to instill in researchers to articulate their work succinctly and gain confidence in delivering apposite scientific presentations. It’s a scientific forum intended to discuss: one’s research findings, learn and understand others research directions, new ideas and troubleshooting if any.
AWS platform provides opportunity for the researchers to talk about their research work carried over the past year and also the work intended to be done. A short abstract of the presentation (250-300 words) is circulated among the team a week prior to the presentation and the researcher is encouraged to present for 30-45 min. only followed by 15 min of question and answers session. The AWS is scheduled to be held on the second and fourth Monday of every month.
Completed Presentations
| S. No. | Presenter | Principal Investigator | Date | Topic |
| 1 | Raghavendra M | Dr. Kiranam C | 10th April 2023 | A study to characterize the effects of chemical and genetic modulation of tyrosine kinase functions in zebrafish |
| 2 | Kanika C | Dr. Kishore P | 24th April 2023 | Investigation of regulatory role of Ser/Thr phosphatase PHLPP1 in the mitochondrial homeostasis |
| 3 | Rathin B | Dr. Parimal M | 22nd May 2023 | Studies on incretin receptor agonism to ameliorate type-2 diabetes and obesity |
| 4 | Rebeccakristina E | Dr. Parimal M | 12th June 2023 | Characterization of the functional role of PRIP interacting protein with methyl transferase domain (PIMT) in adipogenesis and lipid metabolism |
| 5 | Nagalakshmi C | Dr. Parimal M | 26th June 2023 | Investigation of the functional role of PRIP interacting protein with methyl transferase domain (PIMT) in macrophages and their interactions with other metabolic tissues |
| 6 | Harshavardhan B | Dr. Manojit Pal | 10th July 2023 | Design, synthesis and evaluation of 2-aryl quinoline derivatives against 12R-lipoxygenase (12R-LOX): Discovery of first inhibitor of 12R-LOX |
| 7 | Krishnaveni Y | Dr. Kiranam C | 21st August 2023 | Cellular Effects of ARSK Knockout and Overexpression |
| 8 | Sushmasri N | Dr. Aarti S | 28th August 2023 | Elucidating the function of Phosphatidylserine decarboxylase (PISD) during early development using zebrafish as model organism |
| 9 | Ritarani V | Dr. Aarti S | 11th September 2023 | Functional characterization of the kitlg in zebrafish |
| 10 | Sailatha S | Dr. Kishore P | 9th October 2023 | Elucidation of the physiological role of MAGMAS: Implications in mitochondrial skeletal disorders |
| 11 | Christopher Shamir M | Dr. Kiranam C | 16th October 2023 | Deciphering the mechanistic role of AIMP2 in hypomyelinating leukodystrophy |
| 12 | Kailash C | Dr. Kishore P | 30th October 2023 | Functional exploration of EXOC6b protein in ciliogenesis and autophagy |
| 13 | Aishwarya M | Dr. Kishore P | 27th November 2023 | Understanding the regulatory role of co-activator binding protein PIMT in the pancreatic β-cells of diabetic animals and T3c diabetic (chronic pancreatitis) humans |
| 14 | Sooraj G | Dr. Kishore P | 11th December 2023 | Functional analysis of PHLPP1 in skeletal myogenesis |
| 15 | Hamsini S | Dr. Aarti S | 8th January 2024 | Characterization of the effect of mutations in Glucocerebrosidase enzyme on its activity and interaction with co-activator – Saposin C |
| 16 | Roumi N | Dr. Sandipan C | 22nd January 2024 | Decoding the AAV2 capsid assembly and host receptor recognition mechanism |
| 17 | Venkatesh G | Dr. Neelima D | 13th February 2024 | Disease modelling using in vitro and in vivo systems |
| 18 | Sruthi P | Dr. Sandipan C | 26th February 2024 | Contrasting effects of DHA and EPA on POPC-cholesterol lipid bilayer |
| 19 | Sai Aneesh | Dr. Aarti S | 08th April 2024 | Zebrafish as a model for Methylmalonyl Acedemia: Investigating novel therapeutic approaches |
| 20 | Dr. Kiranam Chatti | NA | 22nd April 2024 | Zebrafish as a model to study caffeine action, and its relevance to health |
| 21 | Dr. Kishore Parsa | NA | 06th May 2024 | PHLPP1: A new mediator of endoplasmic reticulum stress |
| 22 | Dr. Marina Rajadurai | NA | 27th May 2024 | Enhancing cancer therapy: Case study on organ-specific delivery and retention of drug-loaded magnetic nanoparticles |
| 23 | Dr. Aarti Sevilimedu | NA | 10th June 2024 | Impaired ovarian development in a zebrafish fmr1 knockout mode |
| 24 | Dr. Tandrika Chattopadhyay | NA | 24th June 2024 | Oscillatory control of Metabolic Homeostasis |
|
25 |
Dr. Sandipan | NA | 08th July 2024 |
Riding the SARS-CoV2 waves: Challenges, Excitement and Surprises |
|
26 |
Dr. Neelima Dubey | NA | 22nd July 2024 |
Allostatic Overload to Mood Disorders |
|
27 |
Krishnanand Pandey | Dr. Kishore Parsa | 09th September 2024 |
Understanding the functions of EXOSC1, associated with pontocerebellar hypoplasia, using cellular and zebrafish model systems. |
|
28 |
Kaushik Sarkar | Dr. Manojit Pal | 23rd September 2024 |
Synthesis and Evaluation of Fused Heterocycles as Potential Agonists of 5-HT2C Receptor |
|
29 |
Soundharya H | Dr. Sandipan C | 07th October 2024 |
Cholesterol Allosterically Modulates the Structure and Dynamics of the Taurocholate Export Pump (ABCB11) |
|
30 |
Dr. Raghavender M | Dr. Kiranam Chatti | 21st October 2024 |
Leveraging Zebrafish for Advancing Disease Biology, Pharmacology, and Toxicology: Insights from NASH, Genotoxicity, and Inflammatory Models |
|
31 |
Krishnaveni Y | Dr. Kiranam Chatti | 25th November 2024 |
Cellular Effects of ARSK Knockout and Overexpression |
|
32 |
Deepesh | Dr. Manojit Pal | 9th December 2024 |
The Potential of Chorismate Mutase Inhibition for Targeting Tuberculosis: Synthesis and Characterization of Fused Bicyclic Nitrogen Based Heterocycles |
|
33 |
Sushma Sri | Dr. Aarti S | 23rd December 2024 |
Elucidating the function of phosphatidylserine decarboxylase (pisd) during early development using zebrafish as model organism |
|
34 |
Christopher Shamir | Dr. Kiranam C | 20th January 2025 |
Deciphering the mechanistic role of AIMP2 in hypomyelinating leukodystrophy |
|
35 |
Dr. Parimal Misra | NA | 27th January 2025 |
Great fat ball: How to control obesity by targeting Perilipin? |
|
36 |
Sooraj Gopan | Dr. Kishore Parsa | 10th February 2025 |
Functional analysis of PHLPP1 in skeletal Myogenesis |
|
37 |
Sagarika | Dr. Tandrika Chattopadhyay | 10th March 2025 |
Development of a Cellular Model of Non-Alcoholic Fatty Liver Disease (NAFLD) |
|
38 |
Aishwarya | Dr. Kishore Parsa | 24th March 2025 |
Role of PRIP-Interacting protein with Methyl Transferase domain (PIMT) in IFN signalling pathway |
|
39 |
Tarasha | Dr. Aarti S | 14th April 2025 |
Functional Analysis of PHLPP1 in Myogenesis: Implications for skeletal muscle dystrophies. |
|
40 |
Sruthi Peesapati | Dr. Sandipan Chakraborty | 5th May 2025 |
Altered Composition of Ceramides and Sphingomyelin Distinctly Modulates the Organizational Landscape and Microdomain Dynamics of Neuronal Plasma Membrane: A Computational Microscopy of Alzheimer’s Brain |
|
41 |
Feroz Ahmed | Dr. Aarti S | 12th May 2025 |
Repositioning of mitochondria-targeted FDA approved small molecules, and development and testing of a novel mRNA-based MFN2 gene therapy for Mitochondrial Skeletal Disorders (MSDs) |
|
42 |
Divya | Dr. Kishore Parsa | 26th May 2025 |
Analysis of patient specific GABPA frameshift mutation (Q423EFS*31) on mitochondrial function |
|
43 |
Roumi N | Dr. Sandipan Chakraborty | 09th June 2025 |
Understanding the host cell surface receptor recognition by adeno associated virus 2 capsid protein and its modulation through allostery-driven mutations: An integrative modelling and simulation approach |
|
44 |
Vasu | Dr. Aarti S | 23rd June 2025 |
Investigating kit ligand function during development in the zebrafish model |
|
45 |
Gayatri | Dr. Tandrika Chattopadhyay | 14th July 2025 |
Understanding the role of dietary inputs in tissue resident macrophage biology |
|
46 |
Pallavi J | Dr. Sandipan Chakraborty | 28th July 2025 |
Exploring Microbial Symbiosis and Antimicrobial Resistance Through the Lens of Metagenomics |
|
47 |
Nikhil | Dr. Kishore Parsa | 11th August 2025 |
Developing Gene Therapies for Glutaric Aciduria Type I |